Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Scientists found that nasal cells act as a first line of defense against the common cold, working together to block ...
After two years of lower levels of impatiens necrotic spot virus in the Salinas Valley, researchers have recorded a higher ...
According to the Iowa Department of Natural Resources' 2025 peregrine falcon report, four peregrine falcons died from the highly pathogenic avian influenza outside of nesting season that year.
A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...
Thanks to a new sampling technique, scientists can now monitor whale health in a non-invasive way. While this development is ...
When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...
When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...
Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results